TELCON RF PHARMACEUTICAL. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	34,384	3,306	8,519	9,734	23,195	24,542
Short-Term Investments	-	731	2,000	-	-	188.64
Trading Asset Securities	6,000	6,000	-	-	-	-
Cash & Short-Term Investments	40,384	10,037	10,519	9,734	23,195	24,730
Cash Growth	526.30%	-4.58%	8.07%	-58.04%	-6.21%	55.66%
Accounts Receivable	4,814	8,748	8,991	6,139	9,479	8,550
Other Receivables	629.2	232.79	177.97	267.88	224.23	2,214
Receivables	5,527	9,060	16,222	6,439	9,703	10,764
Inventory	5,496	4,956	5,003	4,622	4,303	4,276
Prepaid Expenses	170.76	223.42	83.2	73.74	98.87	105.63
Other Current Assets	1,169	1,735	1,161	2,258	55.98	280.83
Total Current Assets	52,747	26,011	32,989	23,127	37,357	40,158
Property, Plant & Equipment	11,594	11,180	8,468	8,038	9,320	8,417
Long-Term Investments	72,762	94,886	74,800	63,375	90,287	103,415
Other Intangible Assets	16,860	18,738	21,338	23,881	30,201	32,153
Long-Term Accounts Receivable	-	-	-	-	-0	-0
Other Long-Term Assets	2,543	2,703	2,774	799.52	864.83	909.05
Total Assets	156,554	153,588	140,415	119,255	168,030	185,053
Accounts Payable	2,900	2,818	2,581	2,668	2,630	2,639
Accrued Expenses	1,169	899.94	697.9	720.39	901.94	1,108
Short-Term Debt	31,984	54,663	26,443	28,853	53,991	84,883
Current Portion of Long-Term Debt	-0	0	0	0	0	240
Current Portion of Leases	528.46	437.95	577.16	694.1	644.11	618.92
Other Current Liabilities	16,278	10,901	4,625	1,394	1,946	1,433
Total Current Liabilities	52,860	69,720	34,924	34,329	60,113	90,921
Long-Term Debt	-	-	-	-	-	900
Long-Term Leases	1,527	589.71	403.02	727.85	1,301	1,674
Other Long-Term Liabilities	152.92	143.39	143.41	62.77	7.91	81.39
Total Liabilities	54,540	70,453	35,470	35,120	61,422	93,577
Common Stock	68,524	12,025	11,599	10,860	9,991	8,751
Additional Paid-In Capital	229,418	245,985	243,907	238,108	216,003	180,991
Retained Earnings	-201,769	-180,462	-154,142	-168,048	-126,310	-103,212
Treasury Stock	-56.04	-56.04	-	-	-	-
Comprehensive Income & Other	5,578	5,337	3,094	3,203	6,896	4,809
Total Common Equity	101,695	82,830	104,459	84,123	106,580	91,339
Minority Interest	319.31	305.35	485.46	12.26	27.59	136.38
Shareholders' Equity	102,014	83,135	104,945	84,135	106,608	91,475
Total Liabilities & Equity	156,554	153,588	140,415	119,255	168,030	185,053
Total Debt	34,040	55,691	27,423	30,275	55,936	88,316
Net Cash (Debt)	6,344	-45,654	-16,904	-20,542	-32,741	-63,586
Net Cash Per Share	152.60	-1286.26	-376.79	-498.59	-1242.32	-2476.51
Filing Date Shares Outstanding	68.51	36.08	34.8	32.58	29.97	26.25
Total Common Shares Outstanding	68.51	36.08	34.8	32.58	29.97	26.25
Working Capital	-113.23	-43,709	-1,935	-11,202	-22,756	-50,764
Book Value Per Share	1484.29	2296.03	3001.83	2581.94	3555.91	3479.23
Tangible Book Value	84,834	64,092	83,121	60,242	76,379	59,186
Tangible Book Value Per Share	1238.20	1776.62	2388.64	1848.97	2548.30	2254.46
Land	827.37	827.37	827.37	827.37	827.37	827.37
Buildings	5,407	5,576	5,281	4,974	4,867	3,508
Machinery	10,583	10,720	8,702	8,016	7,927	8,165
Construction In Progress	1,027	1,027	-	325	316	233.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.